Benjamin Brady

7.0k total citations
12 papers, 145 citations indexed

About

Benjamin Brady is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Benjamin Brady has authored 12 papers receiving a total of 145 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 2 papers in Surgery and 2 papers in Molecular Biology. Recurrent topics in Benjamin Brady's work include Cutaneous Melanoma Detection and Management (4 papers), Skin Protection and Aging (2 papers) and melanin and skin pigmentation (2 papers). Benjamin Brady is often cited by papers focused on Cutaneous Melanoma Detection and Management (4 papers), Skin Protection and Aging (2 papers) and melanin and skin pigmentation (2 papers). Benjamin Brady collaborates with scholars based in Australia, United States and Italy. Benjamin Brady's co-authors include William A. Robinson, Peter Gibbs, Richard Kefford, L. Michael Glodé, Lin Qi, Philip R. Clingan, A. Morganti, Peter Hersey, René González and Jonathan Cebon and has published in prestigious journals such as Journal of Clinical Oncology, Molecular Cancer and Dermatology.

In The Last Decade

Benjamin Brady

12 papers receiving 142 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin Brady Australia 7 81 61 22 20 19 12 145
Johny Bombled France 6 111 1.4× 73 1.2× 15 0.7× 28 1.4× 8 0.4× 7 181
Wiebke Antonopoulos Germany 8 107 1.3× 81 1.3× 17 0.8× 40 2.0× 49 2.6× 11 206
Julie‐Ann Cavallo United States 3 121 1.5× 49 0.8× 50 2.3× 43 2.1× 11 0.6× 3 195
Juliet Carmichael United Kingdom 6 72 0.9× 59 1.0× 30 1.4× 33 1.6× 27 1.4× 11 167
Victoria Damerell South Africa 7 87 1.1× 52 0.9× 13 0.6× 30 1.5× 45 2.4× 8 161
Ekaterini Christina Tampaki Switzerland 8 56 0.7× 61 1.0× 18 0.8× 32 1.6× 12 0.6× 15 147
Michael Birrer United States 5 101 1.2× 65 1.1× 18 0.8× 26 1.3× 8 0.4× 9 159
Michaela C. Baldauf Germany 5 136 1.7× 36 0.6× 11 0.5× 41 2.0× 28 1.5× 7 197
Carlos Moran Segura United States 8 110 1.4× 39 0.6× 18 0.8× 18 0.9× 20 1.1× 21 203
Laura M. McDonell Canada 6 95 1.2× 32 0.5× 19 0.9× 12 0.6× 13 0.7× 10 155

Countries citing papers authored by Benjamin Brady

Since Specialization
Citations

This map shows the geographic impact of Benjamin Brady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Brady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Brady more than expected).

Fields of papers citing papers by Benjamin Brady

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Brady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Brady. The network helps show where Benjamin Brady may publish in the future.

Co-authorship network of co-authors of Benjamin Brady

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Brady. A scholar is included among the top collaborators of Benjamin Brady based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Brady. Benjamin Brady is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Adler, Nikki R., William K. Murray, Benjamin Brady, Christopher McCormack, & Yue Pan. (2018). Sweet syndrome associated with ipilimumab in a patient with metastatic melanoma. Clinical and Experimental Dermatology. 43(4). 497–499. 10 indexed citations
2.
Atkinson, Victoria, Georgina V. Long, Alexander M. Menzies, et al.. (2016). Optimizing combination dabrafenib and trametinib therapy in BRAF mutation‐positive advanced melanoma patients: Guidelines from Australian melanoma medical oncologists. Asia-Pacific Journal of Clinical Oncology. 12(S7). 5–12. 18 indexed citations
3.
Sandhu, Shahneen, Stephen Q. Wong, Ismael A. Vergara, et al.. (2016). Circulating tumor DNA (ctDNA) to track responses and to capture the genomic heterogeneity of metastatic melanoma.. Journal of Clinical Oncology. 34(15_suppl). 9582–9582. 1 indexed citations
4.
Wein, Lironne, Christopher Rowe, Benjamin Brady, et al.. (2016). Prevalence of systemic anticancer therapy for patients within the last 30 days of life: experience in a private hospital oncology group. Internal Medicine Journal. 47(3). 280–283. 3 indexed citations
6.
Qi, Lin, William A. Robinson, Benjamin Brady, & L. Michael Glodé. (2004). Migration and invasion of human prostate cancer cells is related to expression of VEGF and its receptors.. PubMed. 23(5A). 3917–22. 28 indexed citations
7.
Robinson, William A., et al.. (2003). The effect of flavopiridol on the growth of p16+ and p16− melanoma cell lines. Melanoma Research. 13(3). 231–238. 8 indexed citations
8.
Gibbs, Peter, Benjamin Brady, & William A. Robinson. (2002). The Genes and Genetics of Malignant Melanoma. Journal of Cutaneous Medicine and Surgery. 6(3). 229–235. 6 indexed citations
9.
Gibbs, Peter, Benjamin Brady, & William A. Robinson. (2002). The Genes and Genetics of Malignant Melanoma. Journal of Cutaneous Medicine and Surgery. 6(3). 229–235. 15 indexed citations
10.
Gibbs, Peter, Benjamin Brady, René González, & William A. Robinson. (2001). Nevi and Melanoma: Lessons from Turner’s Syndrome. Dermatology. 202(1). 1–3. 14 indexed citations
11.
Brady, Benjamin, et al.. (1998). Cerebrovascular disease in type 1A glycogen storage disease. Journal of Clinical Neuroscience. 5(1). 93–94. 1 indexed citations
12.
Brady, Benjamin. (1986). Does your hospital have an organ donation policy?. PubMed. 10(1). 22–3. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026